Immatics CPO reports 211,000 stock options

Accepted by SEC EDGAR 03/18/2026 - 07:26 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Immatics N.V. Chief People Officer Amie Elizabeth Krause reported her initial ownership of stock options in the company. The filing shows a stock option to buy ordinary shares at an exercise price of $10.58 per share, covering 211,000 underlying ordinary shares.

The options vest 25% on the first anniversary of the grant date, October 27, 2025, and then continue vesting in 12 equal quarterly installments over the following three years, and expire on October 26, 2035. This Form 3 does not reflect any buy or sell transaction, only existing derivative holdings.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Krause Amie Elizabeth

Role Chief People Officer

Type	Security	Shares	Price	Value
Holding	Stock Option (Right to Buy)	--	--	--

Holdings: Stock Option (Right to Buy) — 211,000 contracts (Direct)

Footnotes (1)

1. F1. These options to purchase ordinary shares of the Issuer vest 25% on the first anniversary of the grant date, October 27, 2025, then in 12 equal quarterly installments over the following three years.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Immatics (IMTX) Form 3 filed by Amie Elizabeth Krause show?

The Form 3 shows Amie Elizabeth Krause’s initial ownership of stock options in Immatics N.V. It discloses a stock option over 211,000 ordinary shares at a $10.58 exercise price, with vesting beginning in October 2025 and expiring in October 2035.

How many Immatics (IMTX) shares are covered by Amie Krause’s reported stock options?

The reported stock option covers 211,000 underlying ordinary shares of Immatics N.V. These are derivative rights, not currently owned shares, and they vest over time according to the schedule starting October 27, 2025 and ending three years later.

What is the vesting schedule of Amie Krause’s Immatics (IMTX) stock options?

The options vest 25% on October 27, 2025, the first anniversary of the grant date. The remaining 75% then vest in 12 equal quarterly installments over the following three years, providing a gradual, time-based compensation structure tied to continued service.

What is the exercise price and expiration date of the Immatics (IMTX) stock options reported?

The stock options have an exercise price of $10.58 per ordinary share and expire on October 26, 2035. This gives Amie Krause a long-dated right to purchase shares at a fixed price, subject to the vesting conditions being satisfied over time.

Does the Immatics (IMTX) Form 3 for Amie Krause indicate any recent share purchases or sales?

No, the Form 3 does not indicate any recent purchases or sales of Immatics shares. It only reports a holding of stock options over 211,000 underlying ordinary shares as an initial statement of beneficial ownership for a company officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Krause Amie Elizabeth

(Last) (First) (Middle)

PAUL-EHRLICH-STR. 15

(Street)

TUBINGEN 72076

(City) (State) (Zip)

GERMANY

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Immatics N.V. [ IMTX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief People Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	10/26/2035	Ordinary Shares	211,000	$10.58	D

Explanation of Responses:

1. These options to purchase ordinary shares of the Issuer vest 25% on the first anniversary of the grant date, October 27, 2025, then in 12 equal quarterly installments over the following three years.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney

	/s/ Edward Sturchio, attorney-in-fact for Amie Elizabeth Krause	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)